Ftse Mib
34.490,71
0,07%
DAX
18.693,37
0,04%
S&P 500
5.304,72
0,70%
NASDAQ
16.920,79
1,10%
Bitcoin
68.755,18
0,36%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vor Biopharma Inc (VOR) Vor Biopharma Inc (VOR) Notizie

Vor Biopharma Inc

VOR
1,555
-0,055 (-3,42%)
25 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/5/202422:05GLOBEVor Bio Reports First Quarter 2024 Financial Results and..
09/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/5/202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
03/5/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
02/5/202422:01GLOBEVor Bio Appoints Accomplished Oncology and Cancer..
01/4/202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
20/3/202421:05GLOBEVor Bio Reports Fourth Quarter and Full Year 2023 Financial..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
04/3/202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
14/2/202422:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202414:00GLOBEVor Bio to Participate in the Oppenheimer 34th Annual..
02/2/202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
01/2/202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:01GLOBEVor Bio Doses First AML Patient with VCAR33 (ALLO) and..
05/1/202423:03EDGAR2Form 8-K - Current report
21/12/202322:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
01/12/202322:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
27/11/202314:00GLOBEVor Bio to Participate in the JMP Securities Hematology and..
09/11/202322:01GLOBEVor Bio Presents Positive Data Update on Trem-cel at HSCT²..
08/11/202322:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202322:05GLOBEVor Bio Reports Third Quarter 2023 Financial Results and..
07/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
03/11/202313:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
02/11/202314:10EDGAR2Form 8-K - Current report
02/11/202314:01GLOBEMultiple Clinical and Preclinical Presentations at ASH..
03/10/202322:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
25/9/202314:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
06/9/202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202322:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
30/8/202314:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
10/8/202322:05GLOBEVor Bio Reports Second Quarter 2023 Financial Results and..
10/8/202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/8/202314:00GLOBEVor Bio to Participate in the Wedbush PacGrow Healthcare..
09/6/202313:30GLOBESuccessful Primary Engraftment of Trem-cel in First Five AML..
05/6/202314:00GLOBEVor Bio to Participate in the Goldman Sachs Healthcare..
Apertura: 1,63 Min: 1,55 Max: 1,63
Chiusura: 1,61

La tua Cronologia

NASDAQ
VOR
Vor Biopharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network